Friday, August 29, 2025

Digital Pathology, AI, and Coding: Why You've Got to Read AMA "TAB 94"

›
There is an impending boom of new capabilities which will arrive as digital pathology plus AI or machine learning.   There will be an old fa...
Thursday, August 28, 2025

AI Writing Sample: Bio-Rad Holds Webinar on Advances in Droplet Digital PCR (ddPCR)

›
This past week, Bio-Rad offered a detailed webinar update on its droplet digital PCR offerings.   As of August 28, the deck is still online ...

MOLDX Proposes Two LCDs: Thrombophilia Testing, Liver Disease Steatosis Risk

›
MolDx has released two proposed LCDs, DL40238 for genetic testing for hereditary thrombophilia, and DL40187 for risk stratification of meta...
Wednesday, August 27, 2025

Artera, Owkin, on Digital Pathology in Cancer Management

›
Whole-slide imaging codes appear to be on hiatus at AMA CPT ( here ). but in the real world, the field is moving ahead steadily.   Those int...

Decibio Webinar on NGS Trends in Oncology; September 16, 9 Pacific

›
If you track Linked In, several times a month the consultancy Decibio posts a few key graphics from its industry research.   Let DecibBio c...
Tuesday, August 26, 2025

Verily Closes Medical Device Efforts

›
Verily, "eliminated its entire medical devices program" this week.  See an open-access story at TechCrunch and a subscription art...
Monday, August 25, 2025

MolDx New Transplant Rejection Policy - Comment til August 31

›
In a July 17, 2025 blog, I noted that MolDx had rolled out a new proposed solid organ transplant policy, for molecular tests to detect rejec...

Keeping Up with MAGA HHS: (1) MAHA Dashboard, (2) CMMI & MAHA, (3) Techno-CMS. (4) CMS & Fraud, (5) NIH Golden Science Plan

›
 A few days ago, I noted that HHS is recruiting a panel of experts that will help HHS reform the US provider and insurance system.  Here . ...

OpenEvidence (AI for Docs) Gets 100% on US Medical Licensing Exam

›
Open Evidence is AI for clinicians, trained on medical data and with direct access to text in major journals like JAMA and NEJM.   I underst...
Sunday, August 24, 2025

Cost Effectiveness of CGP in Lung Cancer: Spencer et al.

›
Spencer et al. publish a nice health economics paper on the cost effectiveness of CGP.  It compares US and German cost-effectiveness in seve...

Reforming the US Healthcare System: Again

›
HHS and CMS ran call-for-suggestions operations last spring , how can CMS, or HHS as a whole, be revised, reformed, and more effective. Now,...

AMP, CAP, ACCC: New Consensus for HRD Testing

›
See Hsiao et al., August 2025, for a joint consensus recommendation for HRD testing - homologous recombination deficiency. It's open acc...

Decibio: Case Studies on Molecular Test Adoption (#2, Oncotype Dx)

›
Consultancy Decibio is providing a series of case studies (online at Linked In) for adoption of major molecular tests. See Case #2 here (Onc...

Consultancy MA360i Releases Report on Minimal Residual Disease Industry & Policy

›
The consultancy MA360i has released a report on everything connected to minimal residual disease - MRD.    Designed for both commercial and ...
Friday, August 22, 2025

ARPA-H-Update: Adaptive Treatment Selection in Precision Oncology; Funding?

›
Back in March 2024, I wrote a blog about ARPA-H launching a new program called ADAPT (2024 blog here ).   I noted then that Medicare patient...